Flies the key to studying the causes of dementia

May 19, 2017
Nerve cells in normal/ healthy fly brains and in fly brains expressing the two human Tau isoforms. Credit: Dr Torsten Bossing, University of Plymouth

A research team from the University of Plymouth, University of Southampton and the Alexander Fleming Biomedical Sciences Research Center, Vari, Greece, have studied two structurally-similar proteins in the adult brain and have found that they play distinct roles in the development of dementia.

Their study is published in the prestigious journal Neurobiology of Disease.

The understanding and knowledge gained from this study could lead to effective therapies for dementia and other .

Tau proteins stabilise microtubules in the brain and nervous system. Microtubules help form the structure of cells and other functions, such as providing the rail tracks for transport between cells.

In the brain of , the abnormal clumping of Tau proteins have long been linked to changes in nerve cell activation and ultimately cell death. Two structurally different forms of Tau exist. The research team expressed these two forms of human Tau in of the Drosophila (fruit fly) brain, examining their effects on nerve cell survival and activation, fly movement and memory formation.

The results show that these two proteins differ in terms of biology and pathological potential. One leads to poor communication between nerves associated with movement. The other leads to greater neurodegeneration and impairments in learning and memory.

This is important because defects in the proteins have a bearing on neurodegenerative diseases such as dementia. Designing drugs which target each form specifically should help to improve specific symptoms.

Involved in the study from the University of Plymouth is Dr Torsten Bossing. He commented: "With each new discovery like this we move one step closer to finding effective drug treatments for debilitating neurodegenerative diseases. This is an important study carried out using nerve from fruit flies and it has the potential over the coming years to be developed through more testing and clinical trials. We firmly believe that the answer to the question of how we treat conditions such as dementia lies at this cellular level."

Explore further: Scientists discover two repurposed drugs that arrest neurodegeneration in mice

More information: Megan A. Sealey et al, Distinct phenotypes of three-repeat and four-repeat human tau in a transgenic model of tauopathy, Neurobiology of Disease (2017). DOI: 10.1016/j.nbd.2017.05.003

Related Stories

Scientists discover two repurposed drugs that arrest neurodegeneration in mice

April 20, 2017
A team of scientists who a few years ago identified a major pathway that leads to brain cell death in mice, have now found two drugs that block the pathway and prevent neurodegeneration. The drugs caused minimal side effects ...

In Huntington's disease, traffic jams in the cell's control center kill brain cells

May 4, 2017
Working with mouse, fly and human cells and tissue, Johns Hopkins researchers report new evidence that disruptions in the movement of cellular materials in and out of a cell's control center—the nucleus—appear to be a ...

Therapies that target dementia in early stages critical to success

March 28, 2017
Targeting dementia in the earlier stages of the condition could be critical for the success of future therapies, say researchers from the University of Bristol, who have found that the very earliest symptoms of dementia might ...

Drug candidate stabilizes essential transport mechanism in nerve cells

January 31, 2017
Tau is a key brain protein involved in Alzheimer's disease and other brain diseases. Aggregates of Tau known as "neurofibrillary tangles" have been associated with nerve cell death and cognitive decline.

Boosting a cell-protecting protein may help slow Alzheimer's disease progression

March 2, 2017
A new study of Alzheimer's disease by Fiona Kerr and Linda Partridge at University College London, uses mouse and fruit fly models to show that Keap1, which inhibits the protective protein Nrf2, is a promising target for ...

New discovery could be a major advance for neurological diseases

February 13, 2017
The discovery of a new mechanism that controls the way nerve cells in the brain communicate with each other to regulate our learning and long-term memory could have major benefits to understanding how the brain works and ...

Recommended for you

Research redefines proteins' role in the development of spinal sensory cells

September 19, 2017
A recent study led by Samantha Butler at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA has overturned a common belief about how a certain class of proteins in the spinal cord regulate ...

The brain at work: Spotting half-hidden objects

September 19, 2017
How does a driver's brain realize that a stop sign is behind a bush when only a red edge is showing? Or how can a monkey suspect that the yellow sliver in the leaves is a round piece of fruit?

Team discovers how to train damaging inflammatory cells to promote repair after stroke

September 19, 2017
White blood cells called neutrophils are like soldiers in your body that form in the bone marrow and at the first sign of microbial attack, head for the site of injury just as fast as they can to neutralize invading bacteria ...

Epileptic seizures show long-distance effects

September 19, 2017
The area in which an epileptic seizure starts in the brain, may be small but it reaches other parts of the brain at distances of over ten centimeters. That distant activity, in turn, influences the epileptic core, according ...

Study uncovers markers for severe form of multiple sclerosis

September 18, 2017
Scientists have uncovered two closely related cytokines—molecules involved in cell communication and movement—that may explain why some people develop progressive multiple sclerosis (MS), the most severe form of the disease. ...

Genetically altered mice bear some hallmarks of human bipolar behavior

September 18, 2017
Johns Hopkins researchers report they have genetically engineered mice that display many of the behavioral hallmarks of human bipolar disorder, and that the abnormal behaviors the rodents show can be reversed using well-established ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.